| Serial Number | 97576507 |
| Word Mark | MEDFUSE |
| Filing Date | Friday, September 2, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, January 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of a stylized design of two bold outlined leaves cured toward each other with seven fuse-like images extended from one side of the leaf design toward the perimeter to form a circular shape with openings on the top and bottom of the circle of the circle centered to the left of the word MedFuse in bold lettering. |
| Pseudo Mark | MED FUSE |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Business and management consulting for medical and healthcare providers and related businesses; Business and management consulting for the pharmaceutical industry; Consulting in the fields of healthcare operations management, hospital operations management, and pharmaceuticals; Consulting services in the field of patient relationship management for healthcare providers; Consulting services in the cost management of health care; Business management and consulting services for the health care industry in the fields of strategic business objectives, reducing costs, increasing revenue, and advancing population health; Business consulting for the medical and healthcare industry, namely, the collection, reporting and analysis of healthcare quality data for networks of health care providers for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting in the field of clinical trials, namely, compilation of computerized databases in the field of clinical trials for business purposes |
| Goods and Services | Providing medical information and pharmaceutical information; Providing medical information and data through the use of a data storage and retrieval system; Providing an internet-based database that provides information in the field of medicine, healthcare, pharmaceuticals, healthcare providers, patient claims, and medical information; Providing an internet-based database of de-identified patient claims data, including pharmacy claims, hospital claims, long-term care claims and ambulatory claims; Providing an internet-based database of physician demographics, namely, age, gender, specialty, geographic locations, practice affiliations, education, publications, speaking engagements, and other thought leadership activities |
| Goods and Services | Providing information about medical research; Compiling data for research purposes in the field of healthcare, medical science, medical consultancy, and pharmaceuticals; Research services, namely, scientific research conducted using databases; Providing medical and scientific data and research information in the field of clinical trials; Providing on-line non-downloadable computer search engine; Providing on-line non-downloadable search engine and analytical tools for conducting research in the fields of health, medicine, pharmaceuticals, physician demographics, physician mapping, and de-identified patient claims data; Providing on-line non-downloadable computer software and software tools for database management; Providing on-line non-downloadable software and software tools for storing, accessing, and sharing patient medical, health and claims data; Providing on-line non-downloadable database of physician demographics, namely, age, gender, specialty, geographic locations, practice affiliations, education, publications, speaking engagements, and other thought leadership activities; Providing on-line non-downloadable database of de-identified patient claims data, including pharmacy claims, hospital claims, long-term care claims, and ambulatory claims; Providing on-line non-downloadable software and software tools for conducting identifying clinical research participants and conducting clinical research in the field of medicine, healthcare, and pharmaceuticals; Providing on-line non-downloadable computer software and software tools for data collection and storage and providing data analytics and data insights; Providing on-line non-downloadable software for use in storing, accessing, sharing, and providing medical information and data on medical professionals, medical thought leaders, physician demographics, physician mapping, and de-identified patient claims; Providing on-line non-downloadable software for conducting research in the fields of medicine, pharmaceuticals, disease management and population health; Software-as-a-service (SAAS) featuring software and software tools for data collection and storage and providing data analytics and data insights; Platform-as-a-service (PAAS) featuring software and software tools for data collection and storage and providing data analytics and data insights; Providing software as a service (SAAS) services featuring software for use in storing, accessing, sharing, and providing medical information and data on medical professionals, medical thought leaders, physician demographics, physician mapping, and de-identified patient claims; Providing platform as a service (PAAS) services featuring software for use in storing, accessing, sharing, and providing medical information and data on medical professionals, medical thought leaders, physician demographics, physician mapping, and de-identified patient claims; Providing software as a service (SAAS) services featuring software for providing users with counseling and monitoring in the fields of medicine, pharmaceuticals, disease management and population health; Providing platform as a service (PAAS) services featuring software for providing users with counseling and monitoring in the fields of medicine, pharmaceuticals, disease management and population health |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 22, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, May 20, 2022 |
| First Use In Commerce Date | Friday, May 20, 2022 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 22, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, May 20, 2022 |
| First Use In Commerce Date | Friday, May 20, 2022 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 22, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, May 20, 2022 |
| First Use In Commerce Date | Friday, May 20, 2022 |
| Party Name | DarkMatter2bd, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Holmdel, NJ 07733 |
| Event Date | Event Description |
| Wednesday, January 3, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, January 3, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, January 3, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, September 21, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, September 21, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, June 21, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 21, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 21, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 20, 2023 | ASSIGNED TO EXAMINER |
| Friday, September 23, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, September 22, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 6, 2022 | NEW APPLICATION ENTERED |